pd 98059 has been researched along with Pulmonary Hypertension in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, H | 1 |
Cheng, Y | 1 |
Zong, L | 1 |
Huang, L | 1 |
Qiao, C | 1 |
Li, W | 1 |
Gong, B | 1 |
Hu, J | 1 |
Liu, H | 1 |
Wang, X | 1 |
Zhao, C | 1 |
Yu, L | 1 |
Quinn, DA | 1 |
Garg, HG | 1 |
Hales, CA | 1 |
2 other studies available for pd 98059 and Pulmonary Hypertension
Article | Year |
---|---|
Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
Topics: Animals; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Flavonoids; Hypertension, Pulmonary; Hy | 2017 |
Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension.
Topics: Animals; Cell Cycle Proteins; Cells, Cultured; Cyclin D2; Cyclin-Dependent Kinase 2; Cyclin-Dependen | 2006 |